mBank S.A.
mBank S.A. (BREJY) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for mBank S.A. (BREJY), featuring income statements, balance sheets, and cash flow data.
mBank S.A. (BREJY) Income Statement & Financial Overview
Explore comprehensive income reports for mBank S.A. BREJY, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.09B | $3.15B | $4.79B | $4.20B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $3.09B | $3.15B | $4.79B | $4.20B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $139.87M | $188.14M | $259.83M | $642.28M |
| Operating Expenses | $1.26B | $1.21B | $3.19B | $557.14M |
| Total Costs & Expenses | $1.26B | $1.21B | $3.19B | $2.46B |
| Interest Income | $3.61B | $3.77B | $3.83B | $3.35B |
| Interest Expense | $1.17B | $1.26B | $1.25B | $1.18B |
| Depreciation & Amortization | $148.37M | $168.83M | $148.72M | $144.82M |
| EBITDA | $0.00 | $0.00 | $1.13B | $0.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.24 | $0.00 |
| Operating Income | $1.83B | $1.95B | $1.13B | $1.75B |
| Operating Income Ratio | $0.59 | $0.62 | $0.24 | $0.42 |
| Other Income/Expenses (Net) | -$841.83M | -$1.11B | -$148.72M | -$1.03B |
| Income Before Tax | $989.46M | $837.73M | $984.006M | $719.29M |
| Income Before Tax Ratio | $0.32 | $0.27 | $0.21 | $0.17 |
| Income Tax Expense | $283.79M | -$148.28M | $411.10M | $297.40M |
| Net Income | $705.67M | $986.002M | $572.86M | $421.86M |
| Net Income Ratio | $0.23 | $0.31 | $0.12 | $0.10 |
| EPS | $16.61 | $23.20 | $13.48 | $9.93 |
| Diluted EPS | $16.58 | $23.17 | $13.48 | $9.93 |
| Weighted Avg Shares Outstanding | $42.50M | $42.50M | $42.50M | $42.50M |
| Weighted Avg Shares Outstanding (Diluted) | $42.57M | $42.56M | $42.50M | $42.50M |
The company's financials show resilient growth, with revenue advancing from $4.20B in Q2 2024 to $3.09B in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 100% in Q2 2024. Operating income hit $1.83B last quarter, sustaining a consistent 59% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $0.00. Net income dropped to $705.67M, while earnings per share reached $16.61. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan